Angelo Delmonte

Angelo Delmonte

UNVERIFIED PROFILE

Are you Angelo Delmonte?   Register this Author

Register author
Angelo Delmonte

Angelo Delmonte

Publications by authors named "Angelo Delmonte"

Are you Angelo Delmonte?   Register this Author

47Publications

954Reads

11Profile Views

Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer.

J Oncol 2019 19;2019:7475364. Epub 2019 Aug 19.

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/7475364DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721259PMC
August 2019

BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience.

J Thorac Oncol 2019 Mar;14(3):e57-e59

Azienda Ospedaliero, Universitaria Policlinico S. Orsola, Malpighi di Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.11.036DOI Listing
March 2019

Targeting RET-rearranged non-small-cell lung cancer: future prospects.

Lung Cancer (Auckl) 2019 20;10:27-36. Epub 2019 Mar 20.

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/LCTT.S192830DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433115PMC
March 2019

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer.

Lung Cancer 2018 12 1;126:133-138. Epub 2018 Nov 1.

Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.10.027DOI Listing
December 2018

Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancer.

Biol Rev Camb Philos Soc 2018 11 19;93(4):1735-1746. Epub 2018 Apr 19.

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/brv.12416DOI Listing
November 2018

Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.

N Engl J Med 2018 11 25;379(21):2027-2039. Epub 2018 Sep 25.

From the University of Colorado Cancer Center, Aurora (D.R.C.); Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine (H.R.K.), Samsung Medical Center (M.-J.A.), and Seoul National University Hospital (D.-W.K.), Seoul, National Cancer Center, Goyang (J.-Y.H.), Seoul National University Bundang Hospital, Seongnam (J.-S.L.), and Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju (K.H.L.) - all in South Korea; National Taiwan University Hospital (J.C.-H.Y.) and the Faculty of Medicine, School of Medicine, National Yang-Ming University (G.-C.C.), Taipei, and the Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung (G.-C.C.) - all in Taiwan; the Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology, Department of Respiratory and Critical Care Medicine, Otto Wagner Hospital, Vienna (M.J.H.); Queen Elizabeth Hospital, Kowloon, Hong Kong (J.Y.-C.L.); Azienda Ospedaliera S. Giuseppe Moscati, Avellino (C.G.), the Scientific Institute of Romagna for the Study and Treatment of Cancer, Meldola (A.D.), Centro di Riferimento Oncologico, Istituto Nazionale Tumori, IRCCS Struttura Operativa Complessa Oncologia Medica A, Aviano (A.B.), Thoracic Medical Oncology, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples (A.M.), and the Medical Oncology Unit, University Hospital of Parma, Parma (M.T.) - all in Italy; Complejo Hospitalario Universitario de A Coruña, Coruña (R.G.C.), and Vall d'Hebron University Hospital, Barcelona (E.F.) - both in Spain; the Department of Hematology and Oncology, University Department of Internal Medicine-Oncology, Pius-Hospital Medical Campus, University of Oldenburg, Oldenburg, Germany (F.G.); the Department of Medical Oncology, Christie NHS Foundation Trust, and Division of Cancer Sciences, University of Manchester, Manchester (R.C.), and Guy's and St. Thomas' NHS Foundation Trust (S.G.) and Royal Marsden Hospital and the National Heart and Lung Institute, Imperial College London (S.P.), London - all in the United Kingdom; Virginia Cancer Specialists Research Institute and US Oncology Research, The Woodlands, TX (A.S.); Yale Cancer Center, New Haven, CT (S.N.G.); and Millennium Pharmaceuticals, Cambridge, MA (N.G., J.H., D.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1810171DOI Listing
November 2018

Perspectives in small cell lung cancer: is something moving?

Transl Lung Cancer Res 2017 Dec;6(Suppl 1):S47-S50

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2017.10.12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750163PMC
December 2017

Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection.

BMC Infect Dis 2017 09 25;17(1):644. Epub 2017 Sep 25.

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-017-2736-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613318PMC
September 2017

Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results.

Drugs 2015 Oct;75(15):1757-71

Laboratory of Cellular and Molecular Engineering "S. Cavalcanti", Department of Electrical, Electronic and Information Engineering "G. Marconi" (DEI), University of Bologna, via Venezia 52, 47521, Cesena, FC, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-015-0461-3DOI Listing
October 2015

EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung.

Lung Cancer 2013 Sep 27;81(3):440-444. Epub 2013 Jun 27.

Thoracic and Sarcoma Oncology Unit, Division of New Drug Development and Clinical Pharmacology, Medical Oncology Department, European Institute of Oncology, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.05.019DOI Listing
September 2013

Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trials.

Crit Rev Oncol Hematol 2012 Sep 25;83(3):432-43. Epub 2012 Feb 25.

Medical Oncology Unit of Respiratory Tract and Sarcomas, New Drugs Development Division, European Institute of Oncology, Milan, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10408428110027
Publisher Site
http://dx.doi.org/10.1016/j.critrevonc.2011.12.005DOI Listing
September 2012

AVE8062: a new combretastatin derivative vascular disrupting agent.

Expert Opin Investig Drugs 2009 Oct;18(10):1541-8

Oncology Institute of Southern Switzerland, Ospedale S Giovanni, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543780903213697DOI Listing
October 2009

Beyond monoclonal antibodies: new therapeutic agents in non-Hodgkin's lymphomas.

Oncologist 2009 May 1;14(5):511-25. Epub 2009 May 1.

Oncology Institute of Southern Switzerland, Ospedale S. Giovanni, 6500 Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2008-0214DOI Listing
May 2009

Molecule-targeted agents in endometrial cancer.

Curr Opin Oncol 2008 Sep;20(5):554-9

Oncology Institute of Southern Switzerland, Ospedale S Giovanni, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00001622-200809000-000
Publisher Site
http://dx.doi.org/10.1097/CCO.0b013e32830b0debDOI Listing
September 2008

Radiofrequency ablation combined with percutaneous ethanol injection in the treatment of hepatocellular carcinoma and portal vein neoplastic thrombosis.

Anticancer Res 2004 Jul-Aug;24(4):2419-21

Divisione di Oncologia II, IRCCS Fondazione S. Maugeri, Istituto Scientifico di Pavia, Italy.

View Article

Download full-text PDF

Source
September 2004